Table 1.
Association between miR-1301-3p level and the clinicopathological parameters of pancreatic cancer patients in the study cohort.
| Clinical parameters | miR-1301-3p | P value | |
|---|---|---|---|
| Low (n = 36) | High (n = 36) | ||
| Age (years) | 61 | 64 | 0.327 |
| Gender | 0.637 | ||
| Male | 21 | 18 | |
| Female | 15 | 18 | |
| Pathological differentiation | <0.001 | ||
| Moderate and high | 18 | 33 | |
| Poor | 18 | 3 | |
| Tumor size (cm) | 4.0 ± 1.5 | 3.7 ± 2.1 | 0.608 |
| Resection | 0.018 | ||
| R0 | 24 | 33 | |
| R1 and R2 | 12 | 3 | |
| Numbers of positive lymph node | 5.0 ± 4.5 | 1.5 ± 1.8 | <0.001 |
| Vascular invasion | 0.634 | ||
| Negative | 19 | 22 | |
| Positive | 17 | 14 | |
| TNM stage | 0.285 | ||
| I and IIA | 7 | 12 | |
| IIB and IV | 29 | 24 | |
| Primary tumor | 0.443 | ||
| T1 and T2 | 23 | 27 | |
| T3 and T4 | 13 | 9 | |
| Regional lymph nodes | 0.119 | ||
| N0 | 7 | 14 | |
| N1 and N2 | 29 | 22 | |
| Distant metastases | 0.107 | ||
| Negative | 30 | 35 | |
| Positive | 6 | 1 | |